Instem: Hits over 3-month peak on contract from South Korea's Biotoxtech
03/06/2020 09:27
** IT solutions and service provider's INS.L shares jump
9% to 523.55p, their highest since Feb. 21
** Co wins a contract worth about $1 mln from Biotoxtech
086040.KQ , a South Korean non-clinical contract research
organization
** Majority of the contract will be recognised as revenue in
2020 and the balance in 2021
** Co will provide pre-clinical data collection, analysis
and regulatory submissions management solutions to Biotoxtech's
R&D facility in South Korea's North Chungcheong Province
urn:newsml:reuters.com:*:nASN0007JD
** About 3,900 shares change hands within an hour of
trading, compared with the 30-day average volume of 4,348 shares
** Stock is up 24.3% this year, as of last close
(Reporting by Aniruddha Chakrabarty)
((aniruddha.c.thomsonreuters.com@reuters.net))